Polycistronic vector for human induced pluripotent stem cell production
Methods of producing induced pluripotent stem (iPS) cells are provided. For example, a method of producing an iPS cell from a differentiated cell, which includes transforming the differentiated cell with a first vector comprising a nucleic acid sequence comprising a nucleic acid sequence encoding an Oct4, a nucleic acid sequence encoding a Sox2, and a nucleic acid sequence encoding a Klf4. Each of the nucleic acid sequences are separated from each other by a first and second viral 2A sequence. The method described can further comprise culturing the transformed cell under conditions that allow for the production of an iPS cell and isolating the cultured iPS cell.
1. A vector comprising (i) a nucleic acid sequence encoding an Oct4, (ii) a nucleic acid sequence encoding a Sox2, and (iii) a nucleic acid sequence encoding a Klf4, wherein each of the nucleic acid sequences, (i)-(iii), are separated by a first and second nucleic acid encoding sequence a porcine teschovirus-1 (PTV1) 2A sequence, wherein the vector comprises a nucleic acid sequence encoding SEQ ID NO: 9.
2. The vector of claim 1 , wherein the vector comprises SEQ ID NO:7.
3. The vector of claim 1 , wherein the vector is designed to correct a genetic mutation, the vector further comprising an unmutated nucleic acid sequence of interest and homologous nucleic acid sequences flanking the genetic mutation.
4. The vector of claim 3 , wherein the unmutated nucleic acid sequence of interest comprises the nucleic acid sequence encoding β-globin.
5. The vector of claim 4 , wherein the vector further comprises a first and second loxP sequence.
6. The vector of claim 5 , wherein the vector further comprises a nucleic acid sequence encoding a Cre recombinase operably linked to an inducible promoter.
7. The vector of claim 6 , wherein the inducible promoter comprises a Nanog-responsive thymidine kinase promoter.
8. The vector of claim 1 , wherein the vector is a plasmid, an adenoviral vector or a retroviral vector.
9. The vector of claim 8 , wherein the retroviral vector is a lentiviral vector.
10. The vector of claim 9 , wherein the lentiviral vector is a lentiviral SIN vector.
11. The vector of claim 8 , wherein the retroviral vector comprises a 3′ long terminal repeat.
12. The vector of claim 11 , wherein the retroviral vector further comprises a loxP sequence.
13. The vector of claim 12 , wherein the loxP sequence is in the 3′ long terminal repeat of the lentiviral vector.
14. A kit comprising (i) the vector of claim 1 and (ii) a vector comprising a nucleic acid sequence encoding a Cre recombinase.
15. The vector of claim 1 , wherein the vector comprises SEQ ID NO: 43.